INO - Inovio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 6/5/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.39
52-Week Change 3379.12%
S&P500 52-Week Change 310.64%
52 Week High 319.36
52 Week Low 31.92
50-Day Moving Average 312.63
200-Day Moving Average 36.77

Share Statistics

Avg Vol (3 month) 338.31M
Avg Vol (10 day) 321.66M
Shares Outstanding 5158.1M
Float 154.59M
% Held by Insiders 12.69%
% Held by Institutions 129.41%
Shares Short (May 14, 2020) 422.92M
Short Ratio (May 14, 2020) 40.53
Short % of Float (May 14, 2020) 414.82%
Short % of Shares Outstanding (May 14, 2020) 414.50%
Shares Short (prior month Apr 14, 2020) 420.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-4,058.78%

Management Effectiveness

Return on Assets (ttm)-24.97%
Return on Equity (ttm)-92.55%

Income Statement

Revenue (ttm)2.61M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-53.10%
Gross Profit (ttm)-82.01M
EBITDA -101.49M
Net Income Avi to Common (ttm)-122.68M
Diluted EPS (ttm)-1.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)270M
Total Cash Per Share (mrq)1.71
Total Debt (mrq)98.52M
Total Debt/Equity (mrq)52.45
Current Ratio (mrq)8.53
Book Value Per Share (mrq)1.26

Cash Flow Statement

Operating Cash Flow (ttm)-90.85M
Levered Free Cash Flow (ttm)-50.01M